Global Atherosclerosis Therapeutics Market Growth (Status and Outlook) 2025-2031

December 2025 | 74 pages | ID: GDEB94925ED1EN
LP Information

Abstracts

According to this study, the global Atherosclerosis Therapeutics market size will reach US$ million by 2031.

Atherosclerosis is a disease in which the inside of an artery narrows due to the build up of plaque.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Atherosclerosis Therapeutics Industry Forecast” looks at past sales and reviews total world Atherosclerosis Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Atherosclerosis Therapeutics sales for 2025 through 2031. With Atherosclerosis Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atherosclerosis Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Atherosclerosis Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Atherosclerosis Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Atherosclerosis Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atherosclerosis Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atherosclerosis Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Atherosclerosis Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Small Molecules
• Biologics

Segmentation by Application:

• Hospital
• Clinic
• Research Institute
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca Plc
• Bayer AG
• Merck & Co. Inc.
• Novartis AG
• Sanofi

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Atherosclerosis Therapeutics Market Size (2020-2031)
  2.1.2 Atherosclerosis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Atherosclerosis Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Atherosclerosis Therapeutics Segment by Type
  2.2.1 Small Molecules
  2.2.2 Biologics
2.3 Atherosclerosis Therapeutics Market Size by Type
  2.3.1 Atherosclerosis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Atherosclerosis Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Atherosclerosis Therapeutics Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Research Institute
  2.4.4 Other
2.5 Atherosclerosis Therapeutics Market Size by Application
  2.5.1 Atherosclerosis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Atherosclerosis Therapeutics Market Size Market Share by Application (2020-2025)

3 ATHEROSCLEROSIS THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Atherosclerosis Therapeutics Market Size Market Share by Player
  3.1.1 Global Atherosclerosis Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Atherosclerosis Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Atherosclerosis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ATHEROSCLEROSIS THERAPEUTICS BY REGION

4.1 Atherosclerosis Therapeutics Market Size by Region (2020-2025)
4.2 Global Atherosclerosis Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Atherosclerosis Therapeutics Market Size Growth (2020-2025)
4.4 APAC Atherosclerosis Therapeutics Market Size Growth (2020-2025)
4.5 Europe Atherosclerosis Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Atherosclerosis Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Atherosclerosis Therapeutics Market Size by Country (2020-2025)
5.2 Americas Atherosclerosis Therapeutics Market Size by Type (2020-2025)
5.3 Americas Atherosclerosis Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Atherosclerosis Therapeutics Market Size by Region (2020-2025)
6.2 APAC Atherosclerosis Therapeutics Market Size by Type (2020-2025)
6.3 APAC Atherosclerosis Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Atherosclerosis Therapeutics Market Size by Country (2020-2025)
7.2 Europe Atherosclerosis Therapeutics Market Size by Type (2020-2025)
7.3 Europe Atherosclerosis Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Atherosclerosis Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Atherosclerosis Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Atherosclerosis Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ATHEROSCLEROSIS THERAPEUTICS MARKET FORECAST

10.1 Global Atherosclerosis Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Atherosclerosis Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Atherosclerosis Therapeutics Forecast
  10.1.3 APAC Atherosclerosis Therapeutics Forecast
  10.1.4 Europe Atherosclerosis Therapeutics Forecast
  10.1.5 Middle East & Africa Atherosclerosis Therapeutics Forecast
10.2 Americas Atherosclerosis Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Atherosclerosis Therapeutics Forecast
  10.2.2 Canada Market Atherosclerosis Therapeutics Forecast
  10.2.3 Mexico Market Atherosclerosis Therapeutics Forecast
  10.2.4 Brazil Market Atherosclerosis Therapeutics Forecast
10.3 APAC Atherosclerosis Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Atherosclerosis Therapeutics Market Forecast
  10.3.2 Japan Market Atherosclerosis Therapeutics Forecast
  10.3.3 Korea Market Atherosclerosis Therapeutics Forecast
  10.3.4 Southeast Asia Market Atherosclerosis Therapeutics Forecast
  10.3.5 India Market Atherosclerosis Therapeutics Forecast
  10.3.6 Australia Market Atherosclerosis Therapeutics Forecast
10.4 Europe Atherosclerosis Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Atherosclerosis Therapeutics Forecast
  10.4.2 France Market Atherosclerosis Therapeutics Forecast
  10.4.3 UK Market Atherosclerosis Therapeutics Forecast
  10.4.4 Italy Market Atherosclerosis Therapeutics Forecast
  10.4.5 Russia Market Atherosclerosis Therapeutics Forecast
10.5 Middle East & Africa Atherosclerosis Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Atherosclerosis Therapeutics Forecast
  10.5.2 South Africa Market Atherosclerosis Therapeutics Forecast
  10.5.3 Israel Market Atherosclerosis Therapeutics Forecast
  10.5.4 Turkey Market Atherosclerosis Therapeutics Forecast
10.6 Global Atherosclerosis Therapeutics Forecast by Type (2026-2031)
10.7 Global Atherosclerosis Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Atherosclerosis Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca Plc
  11.1.1 AstraZeneca Plc Company Information
  11.1.2 AstraZeneca Plc Atherosclerosis Therapeutics Product Offered
  11.1.3 AstraZeneca Plc Atherosclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AstraZeneca Plc Main Business Overview
  11.1.5 AstraZeneca Plc Latest Developments
11.2 Bayer AG
  11.2.1 Bayer AG Company Information
  11.2.2 Bayer AG Atherosclerosis Therapeutics Product Offered
  11.2.3 Bayer AG Atherosclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bayer AG Main Business Overview
  11.2.5 Bayer AG Latest Developments
11.3 Merck & Co. Inc.
  11.3.1 Merck & Co. Inc. Company Information
  11.3.2 Merck & Co. Inc. Atherosclerosis Therapeutics Product Offered
  11.3.3 Merck & Co. Inc. Atherosclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Merck & Co. Inc. Main Business Overview
  11.3.5 Merck & Co. Inc. Latest Developments
11.4 Novartis AG
  11.4.1 Novartis AG Company Information
  11.4.2 Novartis AG Atherosclerosis Therapeutics Product Offered
  11.4.3 Novartis AG Atherosclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novartis AG Main Business Overview
  11.4.5 Novartis AG Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi Atherosclerosis Therapeutics Product Offered
  11.5.3 Sanofi Atherosclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Atherosclerosis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Atherosclerosis Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Small Molecules
Table 4. Major Players of Biologics
Table 5. Atherosclerosis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Atherosclerosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Atherosclerosis Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Atherosclerosis Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Atherosclerosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Atherosclerosis Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Atherosclerosis Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Atherosclerosis Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Atherosclerosis Therapeutics Key Players Head office and Products Offered
Table 14. Atherosclerosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Atherosclerosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Atherosclerosis Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Atherosclerosis Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Atherosclerosis Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Atherosclerosis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Atherosclerosis Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Atherosclerosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Atherosclerosis Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Atherosclerosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Atherosclerosis Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Atherosclerosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Atherosclerosis Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Atherosclerosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Atherosclerosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Atherosclerosis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Atherosclerosis Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Atherosclerosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Atherosclerosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Atherosclerosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Atherosclerosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Atherosclerosis Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Atherosclerosis Therapeutics
Table 39. Key Market Challenges & Risks of Atherosclerosis Therapeutics
Table 40. Key Industry Trends of Atherosclerosis Therapeutics
Table 41. Global Atherosclerosis Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Atherosclerosis Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Atherosclerosis Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Atherosclerosis Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. AstraZeneca Plc Details, Company Type, Atherosclerosis Therapeutics Area Served and Its Competitors
Table 46. AstraZeneca Plc Atherosclerosis Therapeutics Product Offered
Table 47. AstraZeneca Plc Atherosclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AstraZeneca Plc Main Business
Table 49. AstraZeneca Plc Latest Developments
Table 50. Bayer AG Details, Company Type, Atherosclerosis Therapeutics Area Served and Its Competitors
Table 51. Bayer AG Atherosclerosis Therapeutics Product Offered
Table 52. Bayer AG Atherosclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Bayer AG Main Business
Table 54. Bayer AG Latest Developments
Table 55. Merck & Co. Inc. Details, Company Type, Atherosclerosis Therapeutics Area Served and Its Competitors
Table 56. Merck & Co. Inc. Atherosclerosis Therapeutics Product Offered
Table 57. Merck & Co. Inc. Atherosclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Merck & Co. Inc. Main Business
Table 59. Merck & Co. Inc. Latest Developments
Table 60. Novartis AG Details, Company Type, Atherosclerosis Therapeutics Area Served and Its Competitors
Table 61. Novartis AG Atherosclerosis Therapeutics Product Offered
Table 62. Novartis AG Atherosclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Novartis AG Main Business
Table 64. Novartis AG Latest Developments
Table 65. Sanofi Details, Company Type, Atherosclerosis Therapeutics Area Served and Its Competitors
Table 66. Sanofi Atherosclerosis Therapeutics Product Offered
Table 67. Sanofi Atherosclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sanofi Main Business
Table 69. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Atherosclerosis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Atherosclerosis Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Atherosclerosis Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Atherosclerosis Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Atherosclerosis Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Atherosclerosis Therapeutics Market Size Market Share by Type in 2024
Figure 10. Atherosclerosis Therapeutics in Hospital
Figure 11. Global Atherosclerosis Therapeutics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Atherosclerosis Therapeutics in Clinic
Figure 13. Global Atherosclerosis Therapeutics Market: Clinic (2020-2025) & ($ millions)
Figure 14. Atherosclerosis Therapeutics in Research Institute
Figure 15. Global Atherosclerosis Therapeutics Market: Research Institute (2020-2025) & ($ millions)
Figure 16. Atherosclerosis Therapeutics in Other
Figure 17. Global Atherosclerosis Therapeutics Market: Other (2020-2025) & ($ millions)
Figure 18. Global Atherosclerosis Therapeutics Market Size Market Share by Application in 2024
Figure 19. Global Atherosclerosis Therapeutics Revenue Market Share by Player in 2024
Figure 20. Global Atherosclerosis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Atherosclerosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. APAC Atherosclerosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Europe Atherosclerosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Atherosclerosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Americas Atherosclerosis Therapeutics Value Market Share by Country in 2024
Figure 26. United States Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Atherosclerosis Therapeutics Market Size Market Share by Region in 2024
Figure 31. APAC Atherosclerosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Atherosclerosis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 33. China Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Atherosclerosis Therapeutics Market Size Market Share by Country in 2024
Figure 40. Europe Atherosclerosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Atherosclerosis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Atherosclerosis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Atherosclerosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Atherosclerosis Therapeutics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Atherosclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. APAC Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Europe Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. United States Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Canada Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. China Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Japan Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Korea Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. India Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Australia Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Germany Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. France Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. UK Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Italy Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Russia Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Israel Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Global Atherosclerosis Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Atherosclerosis Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Atherosclerosis Therapeutics Market Size 2026-2031 ($ millions)